Adult Cardiac Expression of the Activating Transcription Factor 3, ATF3, Promotes Ventricular Hypertrophy

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Koren, Lilach ^a   Elhanani, Ofer ^a   Kehat, Izhak ^a   Hai, Tsonwin ^b   Aronheim, Ami ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; DOXYCYCLINE; MESSENGER RNA; PHENYLEPHRINE; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; FEMALE; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSGENIC MOUSE;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CARDIOMEGALY; EMBRYO, MAMMALIAN; ENDOMYOCARDIAL FIBROSIS; GENE EXPRESSION; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; ORGAN SPECIFICITY;

MUS; MUS MUSCULUS;

EID: 84879744398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068396     Document Type: Article

References (28)

1. Bernardo BC, Weeks KL, Pretorius L, McMullen JR, (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128: 191-227. doi:10.1016/j.pharmthera.2010.04.005. PubMed: 20438756.
2. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, et al. (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-1402. doi:10.1056/NEJMoa020265. PubMed: 12409541.
3. Hsu JC, Bravo R, Taub R, (1992) Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 12: 4654-4665. PubMed: 1406655.
4. Chen BP, Liang G, Whelan J, Hai T, (1994) ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 269: 15819-15826. PubMed: 7515060.
5. Weidenfeld-Baranboim K, Bitton-Worms K, Aronheim A, (2008) TRE-dependent transcription activation by JDP2-CHOP10 association. Nucleic Acids Res 36: 3608-3619. doi:10.1093/nar/gkn268. PubMed: 18463134.
6. Darlyuk-Saadon I, Weidenfeld-Baranboim K, Yokoyama KK, Hai T, Aronheim A, (2012) The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter. Biochim Biophys Acta 1819: 1142-1153. doi:10.1016/j.bbagrm.2012.09.005. PubMed: 22989952.
7. Hai T, editor (2006) The ATF transcription factors in cellular adaptive responses. New York. Beijing, China, and Springer, NY, USA.: Higher Education Press. pp. pp. 329-340.
8. Hai T, Wolford CC, Chang YS, (2010) ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? Gene Expr 15: 1-11. doi:10.3727/105221610X12819686555015. PubMed: 21061913.
9. Okamoto Y, Chaves A, Chen J, Kelley R, Jones K, et al. (2001) Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. Am J Pathol 159: 639-650. doi:10.1016/S0002-9440(10)61735-X. PubMed: 11485922.
10. Nobori K, Ito H, Tamamori-Adachi M, Adachi S, Ono Y, et al. (2002) ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. J Mol Cell Cardiol 34: 1387-1397. doi:10.1006/jmcc.2002.2091. PubMed: 12392999.
11. Hasin T, Elhanani O, Abassi Z, Hai T, Aronheim A, (2011) Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium. Basic Res Cardiol 106: 175-187. doi:10.1007/s00395-010-0145-9. PubMed: 21191795.
12. Zhou H, Shen DF, Bian ZY, Zong J, Deng W, et al. (2011) Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload. PLOS ONE 6: e26744. doi:10.1371/journal.pone.0026744. PubMed: 22053207.
13. Giraldo A, Barrett OP, Tindall MJ, Fuller SJ, Amirak E, et al. (2012) Feedback regulation by Atf3 in the endothelin-1-responsive transcriptome of cardiomyocytes: Egr1 is a principal Atf3 target. Biochem J 444: 343-355. doi:10.1042/BJ20120125. PubMed: 22390138.
14. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, et al. (1991) Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 266: 24613-24620. PubMed: 1722208.
15. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93: 10933-10938. doi:10.1073/pnas.93.20.10933. PubMed: 8855286.
16. Aronheim A, Zandi E, Hennemann H, Elledge S, Karin M, (1997) Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol 17: 3094-3102. PubMed: 9154808.
17. Kehat I, Heinrich R, Ben-Izhak O, Miyazaki H, Gutkind JS, et al. (2006) Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation. Cardiovasc Res 70: 543-554. doi:10.1016/j.cardiores.2006.02.018. PubMed: 16631626.
18. Kehat I, Hasin T, Aronheim A, (2006) The role of basic leucine zipper protein-mediated transcription in physiological and pathological myocardial hypertrophy. Ann N Y Acad Sci 1080: 97-109. doi:10.1196/annals.1380.009. PubMed: 17132778.
19. Huang C, Sheikh F, Hollander M, Cai C, Becker D, et al. (2003) Embryonic atrial function is essential for mouse embryogenesis, cardiac morphogenesis and angiogenesis. Development 130: 6111-6119. doi:10.1242/dev.00831. PubMed: 14573518.
20. van Veen AA, van Rijen HV, Opthof T, (2001) Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res 51: 217-229. doi:10.1016/S0008-6363(01)00324-8. PubMed: 11470461.
21. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, et al. (2010) Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56: 225-231. doi:10.1161/HYPERTENSIONAHA.109.148635. PubMed: 20606113.
22. Hartman MG, Lu D, Kim ML, Kociba GJ, Shukri T, et al. (2004) Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol 24: 5721-5732. doi:10.1128/MCB.24.13.5721-5732.2004. PubMed: 15199129.
23. Pravtcheva DD, Wise TL, Ensor NJ, Ruddle FH, (1994) Mosaic expression of an Hprt transgene integrated in a region of Y heterochromatin. J Exp Zool 268: 452-468. doi:10.1002/jez.1402680606. PubMed: 8176360.
24. Takeda N, Manabe I, (2011) Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling. Int J Inflam: pp. 2011: 535241.
25. Nahrendorf M, Pittet MJ, Swirski FK, (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437-2445. doi:10.1161/CIRCULATIONAHA.109.916346. PubMed: 20530020.
26. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, et al. (2006) Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441: 173-178. doi:10.1038/nature04768. PubMed: 16688168.
27. Takii R, Inouye S, Fujimoto M, Nakamura T, Shinkawa T, et al. (2010) Heat shock transcription factor 1 inhibits expression of IL-6 through activating transcription factor 3. J Immunol 184: 1041-1048. doi:10.4049/jimmunol.0902579. PubMed: 20018623.
28. Zmuda EJ, Viapiano M, Grey ST, Hadley G, Garcia-Ocana A, et al. (2010) Deficiency of Atf3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model. Diabetologia 53: 1438-1450. doi:10.1007/s00125-010-1696-x. PubMed: 20349223.